Ir para o conteúdo principal

United States Últimas notícias

Todas as matérias desta categoria, das mais recentes às mais antigas.

Grafa
Health

Tiziana Life Sciences completes Phase 2a intranasal foralumab MS trial enrollment

Tiziana Life Sciences (NASDAQ:TLSA) announced that the final patient has completed the final visit in its Phase 2a INFORM-MS clinical trial evaluating intranasal foralumab in patients with non-active Secondary Progressive Multiple Sclerosis (na-SPMS).

Leia mais: Tiziana Life Sciences completes Phase 2a intranasal foralumab MS trial enrollment
Bloomberg
Financial

US-China Have Time to Discuss Trade Truce Extension, Greer Says

Trade Representative Jamieson Greer indicated China and the US remain divided on the terms of a trade truce extension. Asked if a three-to six-month extension was under discussion, Greer said "that's probably the right kind of range" though it's unlikely to be announced this week. He spoke on "Bloomberg Surveillance."

Leia mais: US-China Have Time to Discuss Trade Truce Extension, Greer Says
Grafa
Health

NewAmsterdam Pharma receives first global approval for obicetrapib cholesterol drugs

NewAmsterdam Pharma (NASDAQ:NAMS) and partner Menarini Group announced that the European Commission has granted marketing authorization for Ubeslo® (10 mg obicetrapib monotherapy) and Evlarco® (10 mg obicetrapib plus 10 mg ezetimibe).

Leia mais: NewAmsterdam Pharma receives first global approval for obicetrapib cholesterol drugs